Can-Fite Biopharma Ltd
CANF
|
$1.96
-0.51%
700
|
Health Technology
(0.0% 1d) (-10.0% 1m) (10.7% 1y) (0.0% 2d) (-0.5% 3d) (0.0% 7d) (-56.69% volume)
Earnings Calendar:
Market Cap: $ 3,021,140
http://www.canfite.com
Sec Filling | Patents | 8 employees
Can-Fite BioPharma Ltd. engages in the development of drugs for cancer and inflammatory diseases. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.
cancer israel
add to watch list Paper trade email alert is off
Press-releases
Can-Fite: Scientific Article Published by KOL Presents Namodenoson as a Promising Drug Candidate to Treat Advanced Liver Cancer and MASH
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
CANF | $1.96 -0.51% 700
|
Health Technology
|
| O: 4.76%
H: 0.45%
C: -5.91%
drug candidate liver cancer treat namodenoson advanced
Can-Fite: Submits FDA with an IND Application to Conduct Phase IIb Clinical Trial of Namodenoson in MASH Patients
Published: 2024-04-03 (Crawled : 12:00) - biospace.com/
CANF | $1.96 -0.51% 700
|
Health Technology
|
| O: 2.45%
H: 0.87%
C: -0.43%
fda namodenoson application trial
Namodenoson Treatment for Pancreatic and Liver Cancer: Data will be Discussed in Out-licensing and Distribution Partnering Meetings at Bio Europe Conference
Published: 2024-03-11 (Crawled : 12:30) - biospace.com/
CANF | $1.96 -0.51% 700
|
Health Technology
|
| O: -0.45%
H: 2.27%
C: 2.27%
europe liver conference distribution pancreatic treatment namodenoson
Can-Fite Broadens its Strong Intellectual Property (IP) for NASH: Received Patent Allowance in Canada
Published: 2024-02-28 (Crawled : 12:30) - biospace.com/
CANF | $1.96 -0.51% 700
|
Health Technology
|
| O: -1.9%
H: 4.37%
C: 0.98%
patent canada
Can-Fite Expands the Out-Licensing Deal with Ewopharma to Include the Pancreatic Cancer Indication
Published: 2024-01-30 (Crawled : 13:30) - biospace.com/
CANF | $1.96 -0.51% 700
|
Health Technology
|
| O: 5.24%
H: 2.71%
C: -4.75%
cancer pancreatic deal
Can-Fite Received FDA Positive Response to Psoriasis Pediatric Plan
Published: 2023-12-18 (Crawled : 13:30) - biospace.com/
CANF | $1.96 -0.51% 700
|
Health Technology
|
| O: 4.69%
H: 3.77%
C: -2.83%
fda psoriasis positive response
Can-Fite’s Namodenoson for the Treatment of Pancreatic Cancer Patients: Progress in Clinical Development
Published: 2023-12-04 (Crawled : 13:30) - biospace.com/
CANF | $1.96 -0.51% 700
|
Health Technology
|
| O: 0.0%
H: 1.23%
C: -4.92%
cancer pancreatic treatment namodenoson
Can-Fite Announces Exercise of Warrants for Approximately $3.0 Million in Gross Proceeds
Published: 2023-11-21 (Crawled : 19:00) - globenewswire.com
CANF | $1.96 -0.51% 700
|
Health Technology
|
| O: 0.93%
H: 0.0%
C: -2.39%
Can-Fite Issues Business Update: All Clinical Programs and Business Development Activities Remain Solidly on Track
Published: 2023-11-01 (Crawled : 12:00) - biospace.com/
CANF | $1.96 -0.51% 700
|
Health Technology
|
| O: 4.93%
H: 2.81%
C: -0.0%
business
Can-Fite Novel Approach for the Treatment of Pancreatic Carcinoma with Namodenoson Receives Appreciation of the American Association of Cancer Research (AACR)
Published: 2023-09-27 (Crawled : 13:00) - biospace.com/
CANF | $1.96 -0.51% 700
|
Health Technology
|
| O: 5.79%
H: 1.82%
C: -8.76%
association cancer pancreatic treatment namodenoson research
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 54% | 46% |
Top 10 Gainers
CSSE 4 | $0.3499 129.74% 150M
|
Consumer Services
CZOO | $11.04 121.24% 9.6M
|
BOF | $2.05 75.21% 78M
|
AMST | $3.2 60.0% 63M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.05 44.75% 13M
|
Technology Services
TROO | $1.51 38.53% 5.6M
|
Manufacturing
MULN | News | $3.675 34.62% 11M
|
Information
RILY | $27.91 28.5% 8.9M
|
Finance
WHLM | $6.43 26.58% 580K
|
Commercial Services
Last 48 Hours Insiders Buying
MNSB P 310 | $15.805 -3.39% 14K
|
Finance
|
15:30
TPL P 3 | $585.24 -0.44% 8K
|
Miscellaneous
|
15:01
ISBA P 966 | $18.0001 3.1K
|
Finance and Insurance
|
15:01
MEGI | $11.97 -0.08% 61K
|
|
00:30
CTRN P 29000 | $22.1 -0.59% 19K
|
Retail Trade
|
22:00
CONN | $3.735 0.95% 21K
|
Retail Trade
|
21:30
TGEN P 6000 | $0.685 6.6K
|
Utilities
|
18:30
CMTV P 700 | $16.59 1K
|
Finance and Insurance
|
18:30
FNB | $13.56 -0.51% 420K
|
Finance
|
17:30
RMCF | $3.54 2.5K
|
Consumer Non-Durables
|
20:10